Le Lézard
Classified in: Ebola virus, Health, Science and technology

First Weekly Subscription Service to Provide Early Warning of Coming Viral Outbreaks



BOSTON, Sept. 27, 2017 /PRNewswire/ -- Replikins, LLC., a Boston-based biotechnology research and analytics firm, today introduced the first weekly subscription service that can predict the onset of a viral outbreak.  Replikins Gene Surveillancetm was developed after 10 years of successful global predictive trials by the company on influenza H1N1, H2N3, H5N1, H7N9, Mers-CoV, Ebola, Zika, and other viruses.

Figure: Zika Replikins Gene Molecular Evolution 1947-2016

This automated quantitative service has successfully predicted specific virus outbreaks, including their cessation, location, and mutation rates. The Figure shows an example. Preventive efforts can now begin before the actual outbreak.

The subscription rates per year for weekly Replikins Gene Surveillancetm are proportional to the number of specimens in the database at the beginning of each annual subscription for each virus requested.

For more information, please contact:

Samuel Bogoch, MD, PhD
178279@email4pr.com
646-320-5910  

References: 1. Bogoch,S  1st Intnl. Zika Conference, Washington, D.C. February 23, 2017. Slides upon request. 2. Kristi Rosa. Readiness is All: Replikins Give Advance Warning of Zika Outbreaks. Infectious Diseases today. Contagion Live . February 27,2017.

SOURCE Replikins, LLC


These press releases may also interest you

at 00:14
Global Crypto Offering Exchange (GCOX) today announced the signing of the American singer and songwriter Jason Derulo, the latest luminary to join a growing list of international superstars at GCOX. GCOX is a global platform that allows celebrities...

at 00:01
The HDBaseT Alliance, the cross-industry group tasked with promoting and advancing the HDBaseT standard, is pleased to welcome DENSO, a leading supplier of advanced automotive technology, as a Contributor member.  DENSO joins several other companies...

at 00:00
LAS VEGAS, July 18, 2018 /PRNewswire-PRWeb/ -- R3 Stem Cell is now offering effective regenerative medicine therapies for post stroke patients. The procedures are performed by Double Board Certified physicians at the R3 Stem Cell Center of Excellence...

at 00:00
Consumers lack a full understanding of Artificial Intelligence (AI) and are looking to businesses, government and academia for education, according to a FleishmanHillard report released today. The report highlights that 61% of all those surveyed...

17 jui 2018
New Oriental Education and Technology Group Inc. (the "Company" or "New Oriental") , the largest provider of private educational services in China, today announced that its subsidiary, Koolearn Technology Holding Limited ("Koolearn"), a leading...

17 jui 2018
CalAmp , a technology solutions pioneer transforming the global connected economy, today announced the pricing of its private offering of $200 million aggregate principal amount of 2.00% Convertible Senior Notes due 2025 (the "notes") to be offered...




News published on 27 september 2017 at 13:45 and distributed by: